NCT05923736

Brief Summary

The goal of this cross-sectional case control study is to investigate the cardiovascular risk in digital osteoarthritis. This study aims to compare the cardiovascular risk between group of patients with digital osteoarthritis and control group of patients with non-osteoarthritis disease paired by measurement of carotid intima-media thickness. All participants will undergo an ultrasound scan to measure carotid intima media thickness, a clinical assessment with the rheumatologist and a cardiovascular risk assessment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Oct 2023Oct 2026

First Submitted

Initial submission to the registry

June 15, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

June 28, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

October 4, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 4, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 4, 2026

Expected
Last Updated

April 3, 2024

Status Verified

April 1, 2023

Enrollment Period

2 years

First QC Date

June 15, 2023

Last Update Submit

April 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurement of carotid intima-media thickness

    EIM is a non-invasive ultrasound technique in which an ultrasound-generating probe is conventionally placed opposite the right primitive carotid artery. By distinguishing between an inner layer, consisting of the intima and media, and the outer layer, the adventitia, the intima-media thickness can be assessed.

    20 minutes

Secondary Outcomes (4)

  • Cardiovascular risk assessment by SCORE scale

    10 minutes

  • Identify endothelial dysfunction in coronary arteries by reactive hyperemia index score

    15 minutes

  • Measurement of bone mineral density and body mass composition by DXA

    15 minutes

  • Physical performance assessment by measuring the distance covered in metres in 6 minutes over a 30-metre course

    6 minutes

Study Arms (2)

Case group : digital osteoarthritis

OTHER
Other: Intima media thickness ultrasoundOther: hand ultrasoundOther: EndoPAT™ 2000 systemOther: X-ray absorptiometry (DXA)

Control group : lumbago, osteoporosis

OTHER
Other: Intima media thickness ultrasoundOther: hand ultrasoundOther: EndoPAT™ 2000 systemOther: X-ray absorptiometry (DXA)

Interventions

EIM is a non-invasive ultrasound technique in which an ultrasound-generating probe is conventionally placed opposite the right primary carotid artery. By distinguishing between an inner layer, consisting of the intima and media, and the outer layer, the adventitia, the intima-media thickness can be assessed.

Case group : digital osteoarthritisControl group : lumbago, osteoporosis

Performed by the rheumatologist, to quantify the number of synovial thickenings in B mode and the number of synovitis in Doppler mode. The presence or absence of joint erosions on the metacarpophalangeal (MCP), proximal interphalangeal (PPI) or distal interphalangeal (DIP) joints.

Case group : digital osteoarthritisControl group : lumbago, osteoporosis

It's a measurement that detects endothelial dysfunction in coronary arteries using reactive hyperemia.This examination will be carried out in accordance with the manufacturer's instructions by the Rheumatology Department nurse. The patient lies down for the duration of the examination (20 minutes). A probe is placed on the index finger of each hand and a cuff on the left arm. Recording begins with a 5-minute baseline period (at rest), followed by a 5-minute period of arm occlusion, and ends with a 5-minute period of return to normal.

Case group : digital osteoarthritisControl group : lumbago, osteoporosis

This X-ray examination will be carried out on the Hologic device and the analyses by APEX 4.0 software. Two-photon X-ray absorptiometry (DXA) is a method commonly used to measure bone mineral density. It is based on a scan of the body by an X-ray beam at 2 different energy levels, which enables 3 compartments to be individualized: mineral mass, lean mass and fat mass. This low-radiation method (less than a conventional chest X-ray) is regarded as a benchmark for accurate measurement of both bone mineral density and the various body compartments. The examination lasts 10 minutes and is carried out by the department's electroradiology manipulators

Case group : digital osteoarthritisControl group : lumbago, osteoporosis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For all subjects:
  • Adult male or female subject
  • Able to give informed consent to participate in research
  • Affiliated with a Social Security plan
  • For the digital osteoarthritis group:
  • Consultant in Rheumatology at Clermont-Ferrand University Hospital
  • Affected by digital osteoarthritis meeting ACR diagnostic criteria with radiographic signs of osteoarthritis validated by a radiologist.
  • For the control group :
  • Rheumatology consultant at the Clermont-Ferrand University Hospital or hospitalized in this department for a non-arthritic, non-rheumatic pathology.
  • Patients with spinal disc pathology (lumbago, radiculalgia due to disco-radicular conflict) or non-severe osteoporosis, i.e. with a densitometric T score between -2.5 and -3 DS.

You may not qualify if:

  • For all topics :
  • Refusal to participate
  • Pregnant women, nursing mothers
  • Subjects under guardianship or curatorship, deprived of liberty, or under court protection
  • For the digital osteoarthritis group:
  • For the control group :
  • Existence of chronic inflammatory rheumatism (rheumatoid arthritis, spondylitis, psoriatic arthritis, lupus, gout, chondrocalcinosis...)
  • Existence of digital osteoarthritis
  • Existence of another painful arthritic site (knee, hip, rachi) Existence of finger pain, whatever the etiology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Clermont Ferrand

Clermont-Ferrand, France

RECRUITING

MeSH Terms

Conditions

Low Back PainOsteoporosis

Interventions

Absorptiometry, Photon

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBone Diseases, MetabolicBone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

RadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Sylvain Mathieu

    University Hospital, Clermont-Ferrand

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: It's a cross-sectional case-control study. The study will include patients with digital osteoarthritis as case group and patients with lumbago and osteoporosis without a inflammatory arthritis as control group.Imaging exams will be added for research purposes, and are not part of routine care or diagnosis of these conditions: intima-media thickness, arterial compliance and arterial composition; these tests involve minimal risk.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 15, 2023

First Posted

June 28, 2023

Study Start

October 4, 2023

Primary Completion

October 4, 2025

Study Completion (Estimated)

October 4, 2026

Last Updated

April 3, 2024

Record last verified: 2023-04

Locations